|
High Throughput 3D Cell Assay for Metastatic Prostate Cancer
|
1R41CA165463-01A1
|
$199,134
|
$199,134
|
TAKAYAMA, SHUICHI
|
3D BIOMATRIX, INC.
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
5R44CA112852-05
|
$941,541
|
$941,541
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Automated Systems for Detection and Molecular Characterization of Circulating Tum
|
5R44CA122444-06
|
$979,021
|
$489,511
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-19
|
$272,648
|
$272,648
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Concerted role for integrin alpha3beta1 and TGFb signaling in cancer progression
|
5F32CA153976-02
|
$53,942
|
$53,942
|
Subbaram, Sita
|
ALBANY MEDICAL COLLEGE
|
|
MOTILITY AND INVASION
|
5P01CA100324-10
|
$2,016,840
|
$2,016,840
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
5R01CA150344-24
|
$353,827
|
$353,827
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
5U54CA163131-02
|
$784,552
|
$784,552
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
PTEN and the molecular genetics of endometrial cancer
|
5R01CA097097-09
|
$314,583
|
$47,187
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$1,202,373
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$80,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$80,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$24,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
5R01CA135061-04
|
$334,117
|
$334,117
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
R-Cadherin in Breast Cancer Suppression
|
5R01CA136854-04
|
$334,117
|
$334,117
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of miRNA-375 in Invasive Phenotype of Head and Neck Squamous Cell Carcinoma
|
1F31CA168337-01
|
$54,871
|
$54,871
|
Jimenez, Lizandra
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Novel approach to study intravasation in primary human breast cancer cells(PQ24)
|
1R01CA170507-01
|
$369,043
|
$369,043
|
oktay, maja
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
|
5U01CA158431-02
|
$335,248
|
$335,248
|
Ostrer, Harry
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Macrophages and Tumor Angiogenesis
|
5R01CA131270-05
|
$318,015
|
$318,015
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Identifying the Mechanisms Governing Mena-Induced Tumor Cell Dissemination
|
5F32CA159663-02
|
$52,190
|
$52,190
|
Roh, Minna
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-03
|
$738,155
|
$738,155
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
|
5R01CA133010-04
|
$395,050
|
$395,050
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
5R01CA164468-02
|
$765,967
|
$765,967
|
Verkhusha, Vladislav
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection
|
5R44CA119565-07
|
$999,610
|
$999,610
|
Sears, Christopher
|
AMBERGEN, INC
|
|
A Small Molecule to Activate Cetuximab to Kill K-RAS Mutant Colorectal Tumors
|
1R41CA174031-01
|
$266,641
|
$266,641
|
Jones, Barry
|
ARISAPH PHARMACEUTICALS, INC.
|
|
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer
|
1R21CA164593-01
|
$212,556
|
$212,556
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Identification of microRNA Biomarkers for Colon Cancer Recurrence Risk Stratifica
|
5R44CA138038-04
|
$301,582
|
$150,791
|
Mambo, Elizabeth
|
ASURAGEN, INC.
|
|
DT-EGF Toxic Fusion Protein for Treatment of Bladder Cancer
|
1R43CA174011-01
|
$149,040
|
$149,040
|
Glode, Mike
|
AURORA ONCOLOGY, INC.
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
3R01CA072038-15S1
|
$49,685
|
$16,396
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
5R01CA072038-15
|
$291,192
|
$96,093
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecularly guided multimodal theranostics for breast cancer
|
5R01CA151962-03
|
$334,627
|
$167,314
|
JOSHI, AMIT
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status
|
5R03CA150027-02
|
$78,250
|
$39,125
|
Kaipparettu, Benny
|
BAYLOR COLLEGE OF MEDICINE
|
|
Understanding the origin and pathogenesis of epithelial ovarian cancer
|
5F32CA159523-02
|
$55,670
|
$55,670
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
Characterization and targeting BRIT1 deficiency in breast cancer
|
5R01CA155151-02
|
$324,738
|
$162,369
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Heparanase Mechanisms in Brain-metastatic Breast Cancer
|
5R01CA160335-02
|
$297,350
|
$297,350
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$2,486
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$4,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$176,085
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of SRC-1 in Breast Cancer
|
2R01CA112403-06A1
|
$269,732
|
$269,732
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND
|
5R00CA151293-03
|
$241,529
|
$241,529
|
Zhang, Xiang
|
BAYLOR COLLEGE OF MEDICINE
|
|
Downstream of Akt in the tumor vessel
|
5R01CA131152-05
|
$452,831
|
$149,434
|
Aird, William
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Transmembrane Signal Modulation by Hyperthermia
|
5R01CA047407-24
|
$280,220
|
$140,110
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Akt isoform-specific signaling in breast cancer metastasis
|
5K99CA157945-02
|
$169,128
|
$169,128
|
Chin, Yuet Ming Rebecca
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-09
|
$1,606,297
|
$144,567
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
VEGFs in tumor lymphatic metastasis
|
5R01CA142262-04
|
$452,526
|
$452,526
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Pericytes in Cancer
|
5R01CA155370-02
|
$361,050
|
$361,050
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Stromal Regulation of Bone Metastasis
|
5U54CA163191-02
|
$902,456
|
$902,456
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Function and Regulation of the Phosphorylation-Specific Prolyl Isomerase Pin1
|
9R01CA167677-13A1
|
$387,585
|
$193,793
|
LU, Kun Ping
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-09
|
$2,300,000
|
$667,000
|
McDermott, David
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Metastatic protein network in BRAFV600E positive human thyroid cancers
|
1R21CA165039-01A1
|
$264,915
|
$264,915
|
Nucera, Carmelo
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Total relevant funding to Metastasis for this search: $396,456,505
|